PR Newswire
Following completion of the acquisition of Vertigrow Technology Ltd, Summerway Capital Plc (AIM: SWC) (renamed as Celadon Pharmaceuticals Plc), now a UK-based pharmaceutical company targeting the research, cultivation, manufacturing and supply of cannabinoid-based medicines, announces the admission of its enlarged issued ordinary share capital to trading on AIM, a market operated by the London Stock Exchange plc at 8.00am today ("Admission"). The change of name on the London Stock Exchange from